Cardiac Insight Companies
leading provider of cardiac monitoring solutions. With their innovative technology and expertise in cardiac diagnostics, Cardiac Insight aims to improve the detection and management of cardiovascular conditions. Their products, including the Cardea SOLO and Cardea 20/20 ECG systems, offer comprehensive cardiac evaluation and specialized care for athletes hearts. The companys achievements include FDA clearance for their Solo ECG interpretative system in 2017 and the development of a handheld 12-lead ECG device that enhances electrocardiogram reliability. Through their partnerships and cutting-edge solutions, Cardiac Insight is revolutionizing the field of cardiac monitoring.
Founded Date:
2011.0
Industry:
AI R&D Pharma (DPI)
Employee Number:
41.0
Headquarters:
Niger
